ConductScience.org, home

Paper39201571

Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues.

Zaher A and 3 others. Int J Mol Sci, 2024. Cited by 17 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues. Papers, record 39201571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201571

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
2.76, provisional
iCite
Revised in PubMed
2026-04-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zaher AAmirahttps://orcid.org/0000-0001-7030-0576
2Petronek MSMichael S
3Allen BGBryan G
4Mapuskar KAKranti Ahttps://orcid.org/0000-0002-7311-7184

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydrogen PeroxideMajor topic
NeoplasmsMajor topic
Humans
Animals
Oxidative Stress
Tumor Microenvironment
Ascorbic Acid
Superoxide Dismutase
Reactive Oxygen Species

Source PubMed

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA217797NCI NIH HHSUnited StatesP01CA217797PubMed and NIHNIH RePORTER
R21CA270742NIH HHSUnited StatesR21CA270742PubMed and NIHNIH RePORTER
R21 CA270742NCI NIH HHSUnited StatesR21CA270742PubMed and NIHNIH RePORTER
P30 CA086862NCI NIH HHSUnited StatesP30CA086862PubMed and NIHNIH RePORTER
L998500-GRadiation Research FoundationPubMedPubMed
P30 CA086862NIH HHSUnited StatesP30CA086862PubMed and NIHNIH RePORTER
P01 CA217797NIH HHSUnited StatesP01CA217797PubMed and NIHNIH RePORTER
NAHolden Comprehensive Cancer CenterPubMedPubMed
NACarver College of MedicinePubMedPubMed

References179

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,075,911Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.Med Princ Pract2013https://conductscience.org/library/papers/23075911PubMed
225,794,772Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells.Breast Cancer Res Treat2015https://conductscience.org/library/papers/25794772PubMed
328,338,196Study on the proliferation of human gastric cancer cell AGS by activation of EGFR in H2O2.Eur Rev Med Pharmacol Sci2017https://conductscience.org/library/papers/28338196PubMed
428,765,155Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy.Cancer Res2017https://conductscience.org/library/papers/28765155PubMed
524,624,330Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).Redox Biol2014https://conductscience.org/library/papers/24624330PubMed
615,705,895Controlling tumor growth by modulating endogenous production of reactive oxygen species.Cancer Res2005https://conductscience.org/library/papers/15705895PubMed
727,143,992The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases.Oxid Med Cell Longev2016https://conductscience.org/library/papers/27143992PubMed
821,778,829Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.Cell Cycle2011https://conductscience.org/library/papers/21778829PubMed
916,675,053Partial volume rat lung irradiation: the protective/mitigating effects of Eukarion-189, a superoxide dismutase-catalase mimetic.Radiother Oncol2006https://conductscience.org/library/papers/16675053PubMed
109,235,895Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide.J Biol Chem1997https://conductscience.org/library/papers/9235895PubMed
1133,723,127Oxidative stress and its role in cancer.J Cancer Res Ther2021https://conductscience.org/library/papers/33723127PubMed
1216,199,533Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene.J Biol Chem2005https://conductscience.org/library/papers/16199533PubMed
1338,927,877Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment.Cancers (Basel)2024https://conductscience.org/library/papers/38927877PubMed
1420,729,205Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase.J Biol Chem2010https://conductscience.org/library/papers/20729205PubMed
1533,980,575Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxide.Sci Transl Med2021https://conductscience.org/library/papers/33980575PubMed
1630,618,620The Binding Properties and Physiological Functions of Recoverin.Front Mol Neurosci2018https://conductscience.org/library/papers/30618620PubMed
1726,340,608Biological chemistry and functionality of protein sulfenic acids and related thiol modifications.Free Radic Res2016https://conductscience.org/library/papers/26340608PubMed
1835,898,616A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35898616PubMed
1926,530,759Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.Int J Radiat Oncol Biol Phys2015https://conductscience.org/library/papers/26530759PubMed
2031,911,474High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/31911474PubMed

See all 179 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42,694,716The Triad of NF-κB, HIF-1α, and Oxidative Stress in Hepatocellular Carcinoma: Pathogenesis, Clinical Challenges, and Therapeutic Potential of CIGB-552 in Liver Transplantation.Int J Biol Sci2026https://conductscience.org/library/papers/42694716PubMed
42,622,966Crosslink Between Neuroinflammation and Oxidative/Nitrosative Status in the Glioblastoma Tumor Microenvironment: Prognostic and Theranostic Impact.J Neuroimmune Pharmacol2026https://conductscience.org/library/papers/42622966PubMed
42,528,415A Ferrous-Supply-Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy.Small2026https://conductscience.org/library/papers/42528415PubMed
41,477,216Exosome-Enhanced Injectable Hydrogels: A Comprehensive Review on Their Emerging Role in Wound Healing.Health Sci Rep2026https://conductscience.org/library/papers/41477216PubMed
40,703,657Harnessing the interaction between redox signaling and senescence to restrain tumor drug resistance.Front Cell Dev Biol2025https://conductscience.org/library/papers/40703657PubMed
40,619,791A Targeted Redox-Active Dual-Action Pt(IV)-Mn(II) Prodrug Displays Enhanced In Vivo Anticancer Activity.Adv Healthc Mater2025https://conductscience.org/library/papers/40619791PubMed
40,480,985A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma.Nat Commun2025https://conductscience.org/library/papers/40480985PubMed
40,352,359Targeted and intelligent nano-drug delivery systems for colorectal cancer treatment.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40352359PubMed
40,161,259
Royal jelly and doxorubicin suppressed tumor cells in the xenograft model of lung cancer via the STAT3/FOXM1/ATG7 signaling pathways in athymic nude mice: a biochemical, immunohistochemically and molecular approach.
Toxicol Res (Camb)2025https://conductscience.org/library/papers/40161259PubMed
40,136,648Breaking the Feedback Loop of β-Cell Failure: Insight into the Pancreatic β-Cell's ER-Mitochondria Redox Balance.Cells2025https://conductscience.org/library/papers/40136648PubMed
39,857,360MOMAST® Downregulates AQP3 Expression and Function in Human Colon Cells.Antioxidants (Basel)2024https://conductscience.org/library/papers/39857360PubMed
39,484,304Exploring Neuroprotection against Radiation-Induced Brain Injury: A Review of Key Compounds.NeuroSci2024https://conductscience.org/library/papers/39484304PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201571

GET https://conductscience.org/api/papers/v1/39201571/references?page=2